$RSSS

Research Solutions, Inc. (RSSS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Research Solutions, Inc. (RSSS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 tm2621884d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (the “ Agreement ”) is entered into by and between David Kutil, an individual (“ you ” or “ your ”), and Research Solutions, Inc., a Nevada corporation (the “ Company ”). Thi

Original reporting
Published Aug 3, 2026, 1:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$RSSS
Neutral
medium confidence
Mentioned
$RSSS
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RSSSNeutralLow
01

Why it matters

The excerpt confirms the CFO role, base salary floor, bonus eligibility for fiscal 2027, and standard termination and 280G parachute payment limitation language, but it does not disclose new financial results or guidance.

02

Market read

This is a governance and compensation update. Without accompanying business metrics or guidance, it is more relevant for longer-horizon positioning than for immediate trading decisions.

03

What to watch

Traders may want to watch for subsequent 8-Ks that clarify whether the appointment coincides with restatements, refinancing, or a broader leadership transition.

Relevance 6/10Novelty 5/10Timing: filed Aug 3, 2026 (pre-market/market open window)

Background

The filing is an SEC Form 8-K (Item 5.02) covering director/officer changes and compensatory arrangements, including an employment agreement for a new CFO.

Company-level read

Ticker impact

$RSSSNeutralMedium confidence
Context

Research Solutions, Inc. disclosed an 8-K with a new employment agreement appointing David Kutil as Chief Financial Officer effective July 30, 2026.

Expected impact

Likely limited near-term impact unless follow-on filings disclose compensation details, transition costs, or strategic shifts.

Evidence & confidence

The disclosure is primarily contractual (salary/bonus/equity eligibility and termination terms) rather than a business performance datapoint.

Market effects

No direct sector read-through; this is company-specific executive/compensation documentation.

None indicated.

None indicated.

Counterpoint

The CFO change could be routine or driven by internal restructuring, so the market may discount it absent performance or strategy updates.

Key entities

  • Research Solutions, Inc.

    Subject of the 8-K; disclosed officer change and compensatory arrangements.

  • David Kutil

    Named as the incoming Chief Financial Officer under an employment agreement effective July 30, 2026.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.